Pharmacological and environmental determinants of relapse to cocaine-seeking behavior

被引:150
作者
Spealman, RD [1 ]
Barrett-Larimore, RL [1 ]
Rowlett, JK [1 ]
Platt, DM [1 ]
Khroyan, TV [1 ]
机构
[1] Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Southborough, MA 01772 USA
关键词
relapse; reinstatement; drug cues; drug priming; stress; cocaine; dopamine agonists and antagonists; D-1- and D-2-like receptor mechanisms; medications development;
D O I
10.1016/S0091-3057(99)00049-0
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Animal models have been developed that simulate relevant features of relapse to cocaine-seeking behavior in humans. These models have provided valuable information about pharmacological and environmental factors that precipitate reinstatement of extinguished cocaine-seeking in rats and monkeys, as well as new insights about potential pharmacotherapies for relapse prevention. Reinstatement of cocaine-seeking behavior in animals can be induced by cocaine priming or by cocaine-paired environmental stimuli; however, maximum reinstatement of drug-seeking appears to be induced when cocaine priming and cocaine-paired stimuli are combined. Drugs that share cocaine's indirect dopamine agonist properties or that act as direct agonists at D-2-like dopamine receptors also induce reinstatement of cocaine-seeking behavior, whereas with some exceptions (e.g., caffeine, morphine) drugs from other pharmacological classes do not. D-1-like receptor agonists block rather than mimic the priming effects of cocaine, suggesting different roles for D-1- and D-2-like receptor mechanisms in cocaine relapse. Although considerable overlap exists, drugs that exhibit cocaine-like discriminative stimulus and/or reinforcing effects in other situations do not invariably induce cocaine-like reinstatement of drug-seeking and vice versa, implying that these effects are not simply different behavioral expressions of a unitary neurobiological process. Finally, recent findings with D-1-like receptor agonists, partial agonists, and antagonists suggest that some of these drugs may be viable candidates for development as antirelapse pharmacotherapies. (C) 1999 Elsevier Science Tnc.
引用
收藏
页码:327 / 336
页数:10
相关论文
共 103 条
[41]  
Hartman D S, 1997, Prog Drug Res, V48, P173
[42]   COCAINE-INDUCED COCAINE CRAVING [J].
JAFFE, JH ;
CASCELLA, NG ;
KUMOR, KM ;
SHERER, MA .
PSYCHOPHARMACOLOGY, 1989, 97 (01) :59-64
[43]  
Johanson Chris-Ellyn, 1995, P1685
[44]   LACK OF APPARENT ANTIPSYCHOTIC EFFECT OF THE D-1-DOPAMINE RECEPTOR ANTAGONIST SCH39166 IN ACUTELY ILL SCHIZOPHRENIC-PATIENTS [J].
KARLSSON, P ;
SMITH, L ;
FARDE, L ;
HARNRYD, C ;
SEDVALL, G ;
WIESEL, FA .
PSYCHOPHARMACOLOGY, 1995, 121 (03) :309-316
[45]  
Khroyan TV, 1997, BEHAV PHARMACOL, V8, P65
[46]  
KHROYAN TV, 1999, 61 ANN M COLL PROBL, V75
[47]  
KLEBER HD, 1995, CLIN NEUROPHARMACOL, V18, pS96
[48]   EFFECTS OF BROMOCRIPTINE AND DESIPRAMINE ON BEHAVIOR MAINTAINED BY COCAINE OR FOOD PRESENTATION IN RHESUS-MONKEYS [J].
KLEVEN, MS ;
WOOLVERTON, WL .
PSYCHOPHARMACOLOGY, 1990, 101 (02) :208-213
[49]   THE D1 DOPAMINE RECEPTOR ANTAGONIST SCH-23390 INCREASES COCAINE SELF-ADMINISTRATION IN THE RAT [J].
KOOB, GF ;
LE, HT ;
CREESE, I .
NEUROSCIENCE LETTERS, 1987, 79 (03) :315-320
[50]  
KREEK MJ, 1992, RES P ARNMD, V70, P205